Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kissei Pharmaceutical Co's quarterly market cap
declined
from Sep. 2025 ($1,255.2 Mil) to Dec. 2025 ($1,118.0 Mil) and
declined
from Dec. 2025 ($1,118.0 Mil) to Mar. 2026 ($1,068.2 Mil).
Kissei Pharmaceutical Co's annual market cap
increased
from Mar. 2024 ($1,011.4 Mil) to Mar. 2025 ($1,020.9 Mil) and
increased
from Mar. 2025 ($1,020.9 Mil) to Mar. 2026 ($1,068.2 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Kissei Pharmaceutical Co's Enterprise Value for Today is $695.4 Mil.
Kissei Pharmaceutical Co (OTCPK:KSPHF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Kissei Pharmaceutical Co Market Cap Related Terms
Kissei Pharmaceutical Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Kissei Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kissei Pharmaceutical Co Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kissei Pharmaceutical Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Kissei Pharmaceutical Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Kissei Pharmaceutical Co's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kissei Pharmaceutical Co (KSPHF) has a Market Cap of $1,015.0 Mil as of Aug. 04, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Kissei Pharmaceutical Co and its competitors. According to the industry distribution chart, Kissei Pharmaceutical Co ranks #258 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 25.2%.
Is Kissei Pharmaceutical Co's Market Cap too high?
Kissei Pharmaceutical Co's current Market Cap is $1,015.0 Mil. The Drug Manufacturers industry median Market Cap is 214.68. Kissei Pharmaceutical Co's value of $1,015.0 Mil is 372.8% above this industry median. Based on the distribution chart, Kissei Pharmaceutical Co ranks #258 out of 1024 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Kissei Pharmaceutical Co has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Kissei Pharmaceutical Co's Market Cap compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Kissei Pharmaceutical Co ranks #258 out of 1024 companies for Market Cap. This puts Kissei Pharmaceutical Co in the upper half of its industry. The industry median Market Cap is 214.68. Kissei Pharmaceutical Co's value of $1,015.0 Mil is 372.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 214.68, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kissei Pharmaceutical Co's current Market Cap of $1,015.0 Mil is 372.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Kissei Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Market Cap is 214.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kissei Pharmaceutical Co's current Market Cap is $1,015.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kissei Pharmaceutical Co stock overvalued right now?
Kissei Pharmaceutical Co (KSPHF) has a current Market Cap of $1,015.0 Mil. The stock's GF Value™ is $31.34, compared to a current price of $25.77 — trading 17.8% below its estimated fair value. The current Market Cap is $1,015.0 Mil and 372.8% above the Drug Manufacturers industry median of 214.68. Kissei Pharmaceutical Co's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Kissei Pharmaceutical Co (KSPHF), the current Market Cap is $1,015.0 Mil as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kissei Pharmaceutical Co (KSPHF) Overvalued in 2026?
Based on GuruFocus' analysis, Kissei Pharmaceutical Co stock appears to be undervalued.
The current stock price of $25.77 is trading 17.8% below its estimated GF Value™ of $31.34.
Key valuation signals for KSPHF:
Market Cap: $1,015.0 Mil
GF Value™: $31.34 vs. price of $25.77 (17.8% below fair value)
Industry Position: 372.8% above the Drug Manufacturers median (#258 of 1024)
No single metric tells the full story. See the KSPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
79GF Score
Get the complete analysis for KSPHF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KSPHF has been successfully added to your 
